Mar 28, 2019 · 26 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Mar 21, 2019 · 31 minEpisode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores
Mar 14, 2019 · 31 minEpisode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Mar 7, 2019 · 28 minEpisode 52: Every conceivable angle of Scott Gottlieb's FDA resignation
Feb 28, 2019 · 26 minEpisode 51: CEOs at the Senate, merger mania, and sleuthing startups
Feb 22, 2019 · 13 minEpisode 50: A big scoop on opioid marketing
Feb 21, 2019 · 23 minEpisode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill
Feb 14, 2019 · 23 minEpisode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH
Feb 7, 2019 · 26 minEpisode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?
Jan 31, 2019 · 24 minEpisode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns
Jan 24, 2019 · 24 minEpisode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics
Jan 17, 2019 · 23 minEpisode 44: FDA furloughs, '80s pop radio, and video game therapeutics
Jan 10, 2019 · 14 minEpisode 43: A people's history of J.P. Morgan
Jan 3, 2019 · 22 minEpisode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
Dec 20, 2018 · 26 minEpisode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta
Dec 13, 2018 · 23 minEpisode 40: Gilead’s new boss, the year that was, and the thing about DNA tests
Dec 6, 2018 · 22 minEpisode 39: Using the word 'cure,' an FDA loophole, & making biotech history
Nov 29, 2018 · 23 minEpisode 38: Your guide to the #CRISPRbabies controversy
Nov 15, 2018 · 26 minEpisode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
Nov 8, 2018 · 22 minEpisode 36: What the midterms mean, a golden age on hold, and the $4 million drug